Skip to main content
SpringerLink
Log in

Immunomodulation by Poxviruses

Insights into virus-host interactions by selectively deleting poxvirus genes

  • Chapter
Modulation of Host Gene Expression and Innate Immunity by Viruses

  • 607 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Moss, B. 2001. Poxviridae: The virus and their replication. In Fields Virology, Vol. 2. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams and Wilkins, Philadelphia, p. 2849.

    Google Scholar 

  2. Lucas, M., U. Karrer, A. Lucas, and P. Klenerman. 2001. Viral escape mechanisms-Escapology taught by viruses. Int J Exp Pathol 82:269

    Article  PubMed  CAS  Google Scholar 

  3. Moss, B., and J. L. Shisler. 2001. Immunology 101 at poxvirus U: Immune evasion genes. Semin Immunol 13:59

    Article  PubMed  CAS  Google Scholar 

  4. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 3:36

    Article  PubMed  CAS  Google Scholar 

  5. Seet, B. T., J. B. Johnston, C. R. Brunetti, J. W. Barrett, H. Everett, C. Cameron, J. Sypula, S. H. Nazarian, A. Lucas, and G. McFadden. 2003. Poxviruses and immune evasion. Annu Rev Immunol 21:377

    Article  PubMed  CAS  Google Scholar 

  6. Coen, D. M., and R. F. Ramig. 1996. Viral genetics. In Fields Virology. B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus, eds. Lippincott-Raven, New York, N.Y., p. 113

    Google Scholar 

  7. Smith, K. J., and H. Skelton. 2002. Molluscum contagiosum: Recent advances in pathogenic mechanisms, and new therapies. Am J Clin Dermatol 3:535

    Article  PubMed  Google Scholar 

  8. Flint, S. J., L. W. Enquist, R. M. Krug, V. R. Racaniello, and A. M. Skalka. 2000. Virus cultivation, detection and genetics. In Principles of Virology. ASM Press, Washington, D.C., p. 42

    Google Scholar 

  9. Lee, E. C., D. Yu, J. Martinez de Velasco, L. Tessarollo, D. A. Swing, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2001. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56

    Article  PubMed  CAS  Google Scholar 

  10. Luckow, V. A., S. C. Lee, G. F. Barry, and P. O. Olins. 1993. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J Virol 67:4566.

    PubMed  CAS  Google Scholar 

  11. Adler, H., M. Messerle, and U. H. Koszinowski. 2003. Cloning of herpesviral genomes as bacterial artificial chromosomes. Rev Med Virol 13:111

    Article  PubMed  CAS  Google Scholar 

  12. Domi, A., and B. Moss. 2002. Cloning the vaccinia virus genome as a bacterial artificial chromosome in escherichia coli and recovery of infectious virus in mammalian cells. Proc Natl Acad Sci USA 99:12415

    Article  PubMed  CAS  Google Scholar 

  13. Nash, P., J. Barrett, J. X. Cao, S. Hota-Mitchell, A. S. Lalani, H. Everett, X. M. Xu, J. Robichaud, S. Hnatiuk, C. Ainslie, B. T. Seet, and G. McFadden. 1999. Immunomodulation by viruses: The myxoma virus story. Immunol Rev 168:103

    Article  PubMed  CAS  Google Scholar 

  14. Alcami, A., and U. H. Koszinowski. 2000. Viral mechanisms of immune evasion. Trends Microbiol 8:410

    Article  PubMed  CAS  Google Scholar 

  15. Johnston, J. B., and G. McFadden. 2003. Poxvirus immunomodulatory strategies: Current perspectives. J Virol 77:6093

    Article  PubMed  CAS  Google Scholar 

  16. McFadden, G., and P. M. Murphy. 2000. Host-related immunomodulators encoded by poxviruses and herpesviruses. Cur Opin Microbiol 3:371

    Article  CAS  Google Scholar 

  17. Smith, G. L. 2000. Secreted poxvirus proteins that interact with the immune system. In Effects of Microbes on the Immune System. M. W. Cunningham, and R. S. Fujinami, eds. Lippincott Williams and Wilkins, Philadelphia, p. 491.

    Google Scholar 

  18. Turner, P., and R. Moyer. 2002. Poxvirus immune modulators: Functional insights from animal models. Virus Res 88:35

    Article  PubMed  CAS  Google Scholar 

  19. Zuniga, M. 2002. A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation. Virus Res 88:17

    Article  PubMed  CAS  Google Scholar 

  20. Barry, M., and R. C. Bleackley. 2002. Cytotoxic T lymphocytes: All roads lead to death. Nat Rev Immunol 2:401

    PubMed  CAS  Google Scholar 

  21. Orange, J. S., M. S. Fassett, L. A. Koopman, J. E. Boyson, and J. L. Strominger. 2002. Viral evasion of natural killer cells. Nat Immunol 3:1006

    Article  PubMed  CAS  Google Scholar 

  22. Yewdell, J. W., and A. B. Hill. 2002. Viral interference with antigen presentation. Nat Immunol 3:1019

    Article  PubMed  CAS  Google Scholar 

  23. Boshkov, L. K., J. L. Macen, and G. McFadden. 1992. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J Immunol 148:881

    PubMed  CAS  Google Scholar 

  24. Barry, M., S. F. Lee, L. Boshkov, and G. Mcfadden. 1995. Myxoma virus induces extensive CD4 downregulation and dissociation of p56(lck) in infected rabbit CD4(+) t lymphocytes. J Virol 69:5243

    PubMed  CAS  Google Scholar 

  25. Coscoy, L., and D. Ganem. 2000. Kaposi’s sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA 97:8051

    Article  PubMed  CAS  Google Scholar 

  26. Mansouri, M., E. Bartee, K. Gouveia, B. T. Hovey Nerenberg, J. Barrett, L. Thomas, G. Thomas, G. McFadden, and K. Fruh. 2003. The PHD/LAP-domain protein M153R of myxoma virus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4. J Virol 77:1427

    Article  PubMed  CAS  Google Scholar 

  27. Guerin, J. L., J. Gelfi, S. Boullier, M. Delverdier, F. A. Bellanger, S. Bertagnoli, I. Drexler, G. Sutter, and F. Messud-Petit. 2002. Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J Virol 76:2912

    Article  PubMed  CAS  Google Scholar 

  28. Fruh, K., E. Bartee, K. Gouveia, and M. Mansouri. 2002. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res 88:55

    Article  PubMed  CAS  Google Scholar 

  29. Benedict, C. A., P. S. Norris, and C. F. Ware. 2002. To kill or be killed: Viral evasion of apoptosis. Nat Immunol 3:1013

    Article  PubMed  CAS  Google Scholar 

  30. Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407:770

    CAS  Google Scholar 

  31. Ray, C. A., R. A. Black, S. R. Kronheim, T. A. Greenstreet, P. R. Sleath, G. S. Salvesen, and D. J. Pickup. 1992. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69:597

    Article  PubMed  CAS  Google Scholar 

  32. Tewari, M., and V. M. Dixit. 1995. Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus CrmA gene product. J Biol Chem 270:3255

    Article  PubMed  CAS  Google Scholar 

  33. Tewari, M., W. G. Telford, R. A. Miller, and V. M. Dixit. 1995. Crma, a poxvirusencoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J Biol Chem 270:22705

    Article  PubMed  CAS  Google Scholar 

  34. Dobbelstein, M., and T. Shenk. 1996. Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. J Virol 70:6479

    PubMed  CAS  Google Scholar 

  35. Thompson, J. P., P. C. Turner, A. N. Ali, B. C. Crenshaw, and R. W. Moyer. 1993. The effects of serpin gene mutations on the distinctive pathobiology of cowpox and rabbitpox virus following intranasal inoculation of Balb/c mice. Virology 197:328

    Article  PubMed  CAS  Google Scholar 

  36. Kettle, S., A. Alcami, A. Khanna, R. Ehret, C. Jassoy, and G. L. Smith. 1997. Vaccinia virus serpin b13r (spi-2) inhibits interleukin-1-beta-converting enzyme and protects virus-infected cells from TNF-and Fas-mediated apoptosis, but does not prevent IL-1-beta-induced fever. J Gen Virol 78:677

    PubMed  CAS  Google Scholar 

  37. Messud-Petit, F., J. Gelfi, M. Delverdier, M. F. Amardeilh, R. Py, G. Sutter, and S. Bertagnoli. 1998. Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus. J Virol 72:7830

    PubMed  CAS  Google Scholar 

  38. Petit, F., S. Bertagnoli, J. Gelfi, F. Fassy, C. Boucrautbaralon, and A. Milon. 1996. Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme. J Virol 70:5860

    PubMed  CAS  Google Scholar 

  39. Shisler, J. L., S. N. Isaacs, and B. Moss. 1999. Vaccinia virus serpin-1 deletion mutant exhibits a host range defect characterized by low levels of intermediate and late mRNAs. Virology 262:298

    Article  PubMed  CAS  Google Scholar 

  40. Bertin, J., R. C. Armstrong, S. Ottilie, D. A. Martin, Y. Wang, S. Banks, G. H. Wang, T. G. Senkevich, E. S. Alnemri, B. Moss, M. J. Lenardo, K. J. Tomaselli, and J. I. Cohen. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas-and TNFR1-induced apoptosis. Proc Natl Acad Sci USA 94:1172

    Article  PubMed  CAS  Google Scholar 

  41. Garvey, T. L., J. Bertin, R. M. Siegel, G. H. Wang, M. J. Lenardo, and J. I. Cohen. 2002. Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function. J Virol 76:697

    Article  PubMed  CAS  Google Scholar 

  42. Garvey, T., J. Bertin, R. Siegel, M. Lenardo, and J. Cohen. 2002. The death effector domains (DEDs) of the molluscum contagiosum virus MC159 v-FLIP protein are not functionally interchangeable with each other or with the DEDs of caspase-8. Virology 300:217

    Article  PubMed  CAS  Google Scholar 

  43. Gil, J., J. Rullas, J. Alcami, and M. Esteban. 2001. Mc159l protein from the poxvirus molluscum contagiosum virus inhibits NF-kappa B activation and apoptosis induced by PKR. J Gen Virol 82:3027

    PubMed  CAS  Google Scholar 

  44. Everett, H., M. Barry, S. F. Lee, X. J. Sun, K. Graham, J. Stone, R. C. Bleackley, and G. McFadden. 2000. M11L: A novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J Exp Med 191:1487

    Article  PubMed  CAS  Google Scholar 

  45. Everett, H., M. Barry, X. Sun, S. F. Lee, C. Frantz, L. G. Berthiaume, G. McFadden, and R. C. Bleackley. 2002. The myxoma poxvirus protein, M11L, prevents apoptosis by direct interaction with the mitochondrial permeability transition pore. J Exp Med 196:1127

    Article  PubMed  CAS  Google Scholar 

  46. Barry, M., S. Hnatiuk, K. Mossman, S. F. Lee, L. Boshkov, and G. McFadden. 1997. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology 239:360

    Article  PubMed  CAS  Google Scholar 

  47. Mossman, K., S. F. Lee, M. Barry, L. Boshkov, and G. Mcfadden. 1996. Disruption of M-T5, a novel myxoma virus gene member of the poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J Virol 70:4394

    PubMed  CAS  Google Scholar 

  48. Shisler, J. L., T. G. Senkevich, M. J. Berry, and B. Moss. 1998. Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. Science 279:102

    Article  PubMed  CAS  Google Scholar 

  49. Brick, D. J., R. D. Burke, L. Schiff, and C. Upton. 1998. Shope fibroma virus ring finger protein N1R binds DNA and inhibits apoptosis. Virology 249:42

    Article  PubMed  CAS  Google Scholar 

  50. Brick, D. J., R. D. Burke, A. A. Minkley, and C. Upton. 2000. Ectromelia virus virulence factor p28 acts upstream of caspase-3 in response to UV light-induced apoptosis. J Gen Virol 81:1087

    PubMed  CAS  Google Scholar 

  51. Sen, G. C. 2001. Viruses and interferons. Annu Rev Microbiol 55:255

    Article  PubMed  CAS  Google Scholar 

  52. Barber, G. N. 2001. Host defense, viruses and apoptosis. Cell Death Differ 8:113

    Article  PubMed  CAS  Google Scholar 

  53. Cameron, C., S. Hota-Mitchell, L. Chen, J. Barrett, J. X. Cao, C. Macaulay, D. Willer, D. Evans, and G. McFadden. 1999. The complete DNA sequence of myxoma virus. Virology 264:298

    Article  PubMed  CAS  Google Scholar 

  54. Willer, D. O., G. McFadden, and D. H. Evans. 1999. The complete genome sequence of shope (rabbit) fibroma virus. Virology 264:319

    Article  PubMed  CAS  Google Scholar 

  55. Lee, H. J., K. Essani, and G. L. Smith. 2001. The genome sequence of yaba-like disease virus, a yatapoxvirus. Virology 281:170

    Article  PubMed  CAS  Google Scholar 

  56. McInnes, C. J., A. R. Wood, and A. A. Mercer. 1998. Orf virus encodes a homolog of the vaccinia virus interferon resistance gene E3L. Virus Genes 17:107

    Article  PubMed  CAS  Google Scholar 

  57. Kawagishi-Kobayashi, M., C. N. Cao, J. M. Lu, K. Ozato, and T. E. Dever. 2000. Pseudosubstrate inhibition of protein kinase PKR by swine pox virus C8L gene product. Virology 276:424

    Article  PubMed  CAS  Google Scholar 

  58. Smith, V. P., and A. Alcami. 2002. Inhibition of interferons by ectromelia virus. J Virol 76:1124

    PubMed  CAS  Google Scholar 

  59. Chang, H. W., J. C. Watson, and B. L. Jacobs. 1992. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci USA 89:4825

    Article  PubMed  CAS  Google Scholar 

  60. Sharp, T. V., F. Moonan, A. Romashko, B. Joshi, G. N. Barber, and R. Jagus. 1998. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR-implications for PKR autoregulation. Virology 250:302

    Article  PubMed  CAS  Google Scholar 

  61. Smith, E. J., I. Marie, A. Prakash, A. Garcia-Sastre, and D. E. Levy. 2001. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or I kappa B kinase but is blocked by vaccinia virus E3L protein. J Biol Chem 276:8951

    Article  PubMed  CAS  Google Scholar 

  62. Carroll, K., O. Elroystein, B. Moss, and R. Jagus. 1993. Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor-2-alpha-specific protein kinase. J Biol Chem 268:12837

    PubMed  CAS  Google Scholar 

  63. Langland, J., and B. Jacobs. 2002. The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. Virology 299:133

    Article  PubMed  CAS  Google Scholar 

  64. Brandt, T. A., and B. L. Jacobs. 2001. Both carboxy-and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J Virol 75:850

    Article  PubMed  CAS  Google Scholar 

  65. Najarro, P., P. Traktman, and J. A. Lewis. 2001. Vaccinia virus blocks gamma interferon signal transduction: Viral VH1 phosphatase reverses STAT1 activation. J Virol 75:3185

    Article  PubMed  CAS  Google Scholar 

  66. Harte, M. T., I. R. Haga, G. Maloney, P. Gray, P. C. Reading, N. W. Bartlett, G. L. Smith, A. Bowie, and L. A. O’Neill. 2003. The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense. J Exp Med 197:343

    Article  PubMed  CAS  Google Scholar 

  67. Bowie, A., E. Kiss-Toth, J. A. Symons, G. L. Smith, S. K. Dower, and L. A. J. O’Neill. 2000. A46R and A52R from vaccinia virus are antagonists of host il-1 and toll-like receptor signaling. Proc Natl Acad Sci USA 97:10162

    Article  PubMed  CAS  Google Scholar 

  68. Camus-Bouclainville, C., L. Fiette, S. Bouchiha, B. Pignolet, D. Counor, C. Filipe, J. Gelfi, and F. Messud-Petit. 2004. A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation. J Virol 78:2510

    Article  PubMed  CAS  Google Scholar 

  69. McFadden, G. 2003. Viroceptors: Virus-encoded receptors for cytokines and chemokines. In Cytokines and Chemokines in Infectious Diseases Handbook. M. Kotb, and T. Calandra, eds. Humana Press Inc., Totowa, N.J., p. 285.

    Google Scholar 

  70. Cunnion, K. M. 1999. Tumor necrosis factor receptors encoded by poxviruses. Mol Gen Metab 67:278

    Article  CAS  Google Scholar 

  71. Sedger, L., and G. McFadden. 1996. M-T2: A poxvirus TNF receptor homologue with dual activities. Immunol Cell Biol 74:538

    PubMed  CAS  Google Scholar 

  72. Smith, C. A., T. Davis, J. M. Wignall, W. S. Din, T. Farrah, C. Upton, G. McFadden, and R. G. Goodwin. 1991. T2 open reading frame from the shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun 176:335

    Article  PubMed  CAS  Google Scholar 

  73. Schreiber, M., K. Rajarathnam, and G. Mcfadden. 1996. Myxoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNF alpha, but the dimer is a more potent TNF inhibitor. J Biol Chem 271:13333

    Article  PubMed  CAS  Google Scholar 

  74. Saraiva, M., and A. Alcami. 2001. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J Virol 75:226

    Article  PubMed  CAS  Google Scholar 

  75. Alcami, A., A. Khanna, N. L. Paul, and G. L. Smith. 1999. Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J Gen Virol 80:949

    PubMed  CAS  Google Scholar 

  76. Reading, P. C., A. Khanna, and G. L. Smith. 2002. Vaccinia virus crmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology 292:285

    Article  PubMed  CAS  Google Scholar 

  77. Panus, J. F., C. A. Smith, C. A. Ray, T. D. Smith, D. D. Patel, and D. J. Pickup. 2002. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue. Proc Natl Acad Sci USA 99:8348

    Article  PubMed  CAS  Google Scholar 

  78. Saraiva, M., P. Smith, P. G. Fallon, and A. Alcami. 2002. Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J Exp Med 196:829

    Article  PubMed  CAS  Google Scholar 

  79. Howard, S. T., Y. S. Chan, and G. L. Smith. 1991. Vaccinia virus homologues of the shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. Virology 180:633

    Article  PubMed  CAS  Google Scholar 

  80. Saint, K. M., N. French, and P. Kerr. 2001. Genetic variation in Australian isolates of myxoma virus: An evolutionary and epidemiological study. Arch Virol 146:1105

    Article  PubMed  CAS  Google Scholar 

  81. Macen, J. L., K. A. Graham, S. F. Lee, M. Schreiber, L. K. Boshkov, and G. Mcfadden. 1996. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology 218:232

    Article  PubMed  CAS  Google Scholar 

  82. Upton, C., J. L. Macen, M. Schreiber, and G. McFadden. 1991. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184:370

    PubMed  CAS  Google Scholar 

  83. Alcami, A., and G. L. Smith. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 69:4633

    PubMed  CAS  Google Scholar 

  84. Symons, J. A., A. Alcami, and G. L. Smith. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551

    Article  PubMed  CAS  Google Scholar 

  85. Alcami, A., J. A. Symons, and G. L. Smith. 2000. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol 74:11230

    Article  PubMed  CAS  Google Scholar 

  86. Mossman, K., P. Nation, J. Macen, M. Garbutt, A. Lucas, and G. Mcfadden. 1996. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 215:17

    Article  PubMed  CAS  Google Scholar 

  87. Lalani, A. S., K. Graham, K. Mossman, K. Rajarathnam, I. Clarklewis, D. Kelvin, and G. McFadden. 1997. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J Virol 71:4356

    PubMed  CAS  Google Scholar 

  88. Symons, J. A., D. C. Tscharke, N. Price, and G. L. Smith. 2002. A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. J Gen Virol 83:1953

    PubMed  CAS  Google Scholar 

  89. Verardi, P. H., L. A. Jones, F. H. Aziz, S. Ahmad, and T. D. Yilma. 2001. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated in vivo without a concomitant reduction in immunogenicity. J Virol 75:11

    Article  PubMed  CAS  Google Scholar 

  90. Spriggs, M. K., D. E. Hruby, C. R. Maliszewski, D. J. Pickup, J. E. Sims, R. M. Buller, and J. VanSlyke. 1992. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145

    Article  PubMed  CAS  Google Scholar 

  91. Alcami, A., and G. L. Smith. 1992. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection. Cell 71:153

    Article  PubMed  CAS  Google Scholar 

  92. Born, T. L., L. A. Morrison, D. J. Esteban, T. VandenBos, L. G. Thebeau, N. H. Chen, M. K. Spriggs, J. E. Sims, and R. M. L. Buller. 2000. A poxvirus protein that binds to and inactivates il-18, and inhibits NK cell response. J Immunol 164:3246

    PubMed  CAS  Google Scholar 

  93. Calderara, S., Y. Xiang, and B. Moss. 2001. Orthopoxvirus IL-18 binding proteins: Affinities and antagonist activities. Virology 279:22

    Article  PubMed  CAS  Google Scholar 

  94. Smith, V. P., N. A. Bryant, and A. Alcami. 2000. Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J Gen Virol 81:1223

    PubMed  CAS  Google Scholar 

  95. Xiang, Y., and B. Moss. 1999. Il-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci USA 96:11537

    Article  PubMed  CAS  Google Scholar 

  96. Symons, J. A., E. Adams, D. C. Tscharke, P. C. Reading, H. Waldmann, and G. L. Smith. 2002. The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J Gen Virol 83:2833

    PubMed  CAS  Google Scholar 

  97. Fleming, S. B., C. A. McCaughan, A. E. Andrews, A. D. Nash, and A. A. Mercer. 1997. A homolog of interleukin-10 is encoded by the poxvirus Orf virus. J Virol 71:4857

    PubMed  CAS  Google Scholar 

  98. Imlach, W., C. A. McCaughan, A. A. Mercer, D. Haig, and S. B. Fleming. 2002. Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages. J Gen Virol 83:1049

    PubMed  CAS  Google Scholar 

  99. Lateef, Z., S. Fleming, G. Halliday, L. Faulkner, A. Mercer, and M. Baird. 2003. Orf virus-encoded interleukin-10 inhibits maturation, antigen presentation and migration of murine dendritic cells. J Gen Virol 84:1101

    Article  PubMed  CAS  Google Scholar 

  100. Haig, D. M., J. Thomson, C. McInnes, C. McCaughan, W. Imlach, A. Mercer, and S. Fleming. 2002. Orf virus immuno-modulation and the host immune response. Vet Immunol Immunopathol 87:395

    Article  PubMed  CAS  Google Scholar 

  101. Opgenorth, A., D. Strayer, C. Upton, and G. McFadden. 1992. Deletion of the growth factor gene related to EGF and TGF alpha reduces virulence of malignant rabbit fibroma virus. Virology 186:175

    Article  PubMed  CAS  Google Scholar 

  102. Stroobant, P., A. P. Rice, W. J. Gullick, D. J. Cheng, I. M. Kerr, and M. D. Waterfield. 1985. Purification and characterization of vaccinia virus growth factor. Cell 42:383

    Article  PubMed  CAS  Google Scholar 

  103. Lin, Y. Z., X. H. Ke, and J. P. Tam. 1991. Synthesis and structure-activity study of myxoma virus growth factor. Biochemistry 30:3310

    Article  PubMed  CAS  Google Scholar 

  104. Buller, R. M., S. Chakrabarti, J. A. Cooper, D. R. Twardzik, and B. Moss. 1988. Deletion of the vaccinia virus growth factor gene reduces virus virulence. J Virol 62:866

    PubMed  CAS  Google Scholar 

  105. Opgenorth, A., N. Nation, K. Graham, and G. McFadden. 1993. Transforming growth factor alpha, shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits. Virology 192:701

    Article  PubMed  CAS  Google Scholar 

  106. Meyer, M., M. Clauss, A. Lepple-Wienhues, J. Waltenberger, H. G. Augustin, M. Ziche, C. Lanz, M. Buttner, H. J. Rziha, and C. Dehio. 1999. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (FLT-1) receptor tyrosine kinases. EMBO J 18:363

    Article  PubMed  CAS  Google Scholar 

  107. Wise, L. M., T. Veikkola, A. A. Mercer, L. J. Savory, S. B. Fleming, C. Caesar, A. Vitali, T. Makinen, K. Alitalo, and S. A. Stacker. 1999. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci USA 96:3071

    Article  PubMed  CAS  Google Scholar 

  108. Savory, L. J., S. A. Stacker, S. B. Fleming, B. E. Niven, and A. A. Mercer. 2000. Viral vascular endothelial growth factor plays a critical role in orf virus infection. J Virol 74:10699

    Article  PubMed  CAS  Google Scholar 

  109. Comeau, M. R., R. Johnson, R. F. DuBose, M. Petersen, P. Gearing, T. VandenBos, L. Park, T. Farrah, R. M. Buller, J. I. Cohen, L. D. Strockbine, C. Rauch, and M. K. Spriggs. 1998. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity 8:473

    Article  PubMed  CAS  Google Scholar 

  110. Gardner, J. D., D. C. Tscharke, P. C. Reading, and G. L. Smith. 2001. Vaccinia virus semaphorin A39R is a 50–55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model. J Gen Virol 82:2083

    PubMed  CAS  Google Scholar 

  111. Upton, C., J. L. Macen, D. S. Wishart, and G. McFadden. 1990. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology 179:618

    Article  PubMed  CAS  Google Scholar 

  112. Turner, P. C., and R. W. Moyer. 1995. Orthopoxvirus fusion inhibitor glycoprotein Spi-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion. J Virol 69:5978

    PubMed  CAS  Google Scholar 

  113. Turner, P. C., M. T. Baquero, S. Yuan, S. R. Thoennes, and R. W. Moyer. 2000. The cowpox virus serpin Spi-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin. Virology 272:267

    Article  PubMed  CAS  Google Scholar 

  114. Nash, P., A. Whitty, J. Handwerker, J. Macen, and G. McFadden. 1998. Inhibitory specificity of the anti-inflammatory myxoma virus serpin, Serp-1. J Biol Chem 273:20982

    Article  PubMed  CAS  Google Scholar 

  115. Lomas, D. A., D. L. Evans, C. Upton, G. McFadden, and R. W. Carrell. 1993. Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J Biol Chem 268:516

    PubMed  CAS  Google Scholar 

  116. Wang, Y. X., P. C. Turner, T. L. Ness, K. B. Moon, T. R. Schoeb, and R. W. Moyer. 2000. The cowpox virus Spi-3 and myxoma virus Serp1 serpins are not functionally interchangeable despite their similar proteinase inhibition profiles in vitro. Virology 272:281

    Article  PubMed  CAS  Google Scholar 

  117. Dai, E., H. Guan, L. Liu, S. Little, G. McFadden, S. Vaziri, H. Cao, I. A. Ivanova, L. Bocksch, and A. Lucas. 2003. Serp-1, a viral anti-inflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury. J Biol Chem 278:18563

    Article  PubMed  CAS  Google Scholar 

  118. Mahalingam, S., and G. Karupiah. 2000. Modulation of chemokines by poxvirus infections. Cur Opin Immunol 12:409

    Article  CAS  Google Scholar 

  119. Krathwohl, M. D., R. Hromas, D. R. Brown, H. E. Broxmeyer, and K.H. Fife. 1997. Functional characterization of the C-C chemokine molecules encoded by molluscum contagiosum virus types 1 and 2. Proc Natl Acad Sci USA 94:9875

    Article  PubMed  CAS  Google Scholar 

  120. Smith, C. A., T. D. Smith, P. J. Smolak, D. Friend, H. Hagen, M. Gerhart, L. Park, D. J. Pickup, D. Torrance, K. Mohler, K. Schooley, and R. G. Goodwin. 1997. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236:316

    Article  PubMed  CAS  Google Scholar 

  121. Graham, K. A., A. S. Lalani, J. L. Macen, T. L. Ness, M. Barry, L. Y. Liu, A. Lucas, A. Clarklewis, R. W. Moyer, and G. McFadden. 1997. The T1/35kda family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229:12

    Article  PubMed  CAS  Google Scholar 

  122. Seet, B. T., and G. McFadden. 2002. Viral chemokine-binding proteins. J Leukoc Biol 72:24

    PubMed  CAS  Google Scholar 

  123. Carfi, A., C. A. Smith, P. J. Smolak, J. McGrew, and D. C. Wiley. 1999. Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc Natl Acad Sci USA 96:12379

    Article  PubMed  CAS  Google Scholar 

  124. Lalani, A. S., J. Masters, K. Graham, L. Y. Liu, A. Lucas, and G. McFadden. 1999. Role of the myxoma virus soluble cc-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis. Virology 256:233

    Article  PubMed  CAS  Google Scholar 

  125. Martinezpomares, L., J. P. Thompson, and R. W. Moyer. 1995. Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox virus. Virology 206:591

    Article  CAS  Google Scholar 

  126. Kotwal, G. J. 2000. Poxviral mimicry of complement and chemokine system components: What’s the end game? Immunol Today 21:242

    Article  PubMed  CAS  Google Scholar 

  127. Kotwal, G. J., S. N. Isaacs, R. McKenzie, M. M. Frank, and B. Moss. 1990. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250:827

    PubMed  CAS  Google Scholar 

  128. Sahu, A., S. N. Isaacs, A. M. Soulika, and J. D. Lambris. 1998. Interaction of vaccinia virus complement control protein with human complement proteins-factor I-mediated degradation of C3b to iC3b(1) inactivates the alternative complement pathway. J Immunol 160:5596

    PubMed  CAS  Google Scholar 

  129. Murthy, K. H. M., S. A. Smith, V. K. Ganesh, K. W. Judge, N. Mullin, P. N. Barlow, C. M. Ogata, and G. J. Kotwal. 2001. Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell 104:301

    Article  PubMed  CAS  Google Scholar 

  130. Smith, S. A., N. P. Mullin, J. Parkinson, S. N. Shchelkunov, A. V. Totmenin, V. N. Loparev, R. Srisatjaluk, D. N. Reynolds, K. L. Keeling, D. E. Justus, P. N. Barlow, and G. J. Kotwal. 2000. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: A novel mechanism for evasion of host defense. J Virol 74:5659

    Article  PubMed  CAS  Google Scholar 

  131. Rosengard, A. M., Y. Liu, Z. Nie, and R. Jimenez. 2002. Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement. Proc Natl Acad Sci USA 99:8808

    PubMed  CAS  Google Scholar 

  132. Miller, C. G., S. N. Shchelkunov, and G. J. Kotwal. 1997. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology 229:126

    Article  PubMed  CAS  Google Scholar 

  133. Kotwal, G. J., C. G. Miller, and D. E. Justus. 1998. The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation. Mol Cell Biochem 185:39

    Article  PubMed  CAS  Google Scholar 

  134. Smith, S. A., and G. J. Kotwal. 2001. Virokines: Novel immunomodulatory agents. Expert Opin Biol Ther 1:343

    Article  PubMed  CAS  Google Scholar 

  135. Mayr, A. 2003. Development of a non-immunizing, paraspecific vaccine from attenuated pox viruses: A new type of vaccine. New Microbiol 26:7

    PubMed  CAS  Google Scholar 

  136. Graham, B. S. 2002. Clinical trials of HIV vaccines. Annu Rev Med 53:207

    Article  PubMed  CAS  Google Scholar 

  137. Tartaglia, J., M. C. Bonnet, N. Berinstein, B. Barber, M. Klein, and P. Moingeon. 2001. Therapeutic vaccines against melanoma and colorectal cancer. Vaccine 19:2571

    Article  PubMed  CAS  Google Scholar 

  138. Zavala, F., M. Rodrigues, D. Rodriguez, J. R. Rodriguez, R. S. Nussenzweig, and M. Esteban. 2001. A striking property of recombinant poxviruses: Efficient inducers of in vivo expansion of primed CD8(+) T cells. Virology 280:155

    Article  PubMed  CAS  Google Scholar 

  139. Kaufman, H. L. 2003. The role of poxviruses in tumor immunotherapy. Surgery 134:731

    Article  PubMed  Google Scholar 

  140. Kwak, H., H. Horig, and H. L. Kaufman. 2003. Poxviruses as vectors for cancer immunotherapy. Curr Opin Drug Discov Devel 6:161

    PubMed  CAS  Google Scholar 

  141. Humrich, J., and L. Jenne. 2003. Viral vectors for dendritic cell-based immunotherapy. Curr Top Microbiol Immunol 276:241

    PubMed  CAS  Google Scholar 

  142. Vanderplasschen, A., and P. P. Pastoret. 2003. The uses of poxviruses as vectors. Curr Gene Ther 3:583

    Article  PubMed  CAS  Google Scholar 

  143. Bonilla-Guerrero, R., and G. A. Poland. 2003. Smallpox vaccines: Current and future. J Lab Clin Med 142:252

    Article  PubMed  Google Scholar 

  144. Di Giulio, D. B., and P. B. Eckburg. 2004. Human monkeypox: An emerging zoonosis. Lancet Infect Dis 4:15

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Biotherapeutics Research Group, Robarts Research Institute, London, ON, CAN

    James B. Johnston & Grant McFadden

  2. Department of Microbiology and Immunology, University of Western Ontario, London, ON, CAN

    Grant McFadden

Authors
  1. James B. Johnston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grant McFadden
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Mount Sinai School of Medicine, New York, NY, USA

    Peter Palese

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer

About this chapter

Cite this chapter

Johnston, J.B., McFadden, G. (2005). Immunomodulation by Poxviruses. In: Palese, P. (eds) Modulation of Host Gene Expression and Innate Immunity by Viruses. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3242-0_8

Download citation

Publish with us

Policies and ethics

Search

Navigation